Semaglutide used for weight loss is often not approved by medical health insurance plans and will require out-of-pocket costs for patients
However, overlapping primary studies were predominantly concentrated in a limited number of large-scale, frequently cited RCTs in the field of GLP-1 RAs-such as LEADER, SUSTAIN, EXSCEL, HARMONY Outcomes, REWIND, ELIXA, SELECT, PIONEER, AWARD, AMPLITUDE, LEAD, SCALE, and STEP
YOUR RIGHTS REGARDING YOUR PROTECTED HEALTH INFORMATION Access to medical records: You have the right to access and receive copies of your protected health information that we use to make decisions about your care
Rev Colgio Bras Cir 40:191195 Rye P et al (2018) Efficacy of high-dose liraglutide as an adjunct for weight loss in patients with prior bariatric surgery
CrossRef Hypertension in middle childhood Mirjam Monik, Zala Hrovat, Sonja Golob Jani, Martina Filipi, Mladen Crnobrnja, Nataa Marun Varda BMC Pediatrics .2026;[Epub] CrossRef Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis Akash Roy, Surabhi Jajodia, Shardhya Chakraborty, Shruti Keyal, Awanish Tewari, Nikhil Sonthalia, Sourish Roy, Rajat Khandelwal, Anand Kulkarni, Uday Chand Ghoshal, Rajender Reddy, Mahesh Kumar Goenka BMC Gastroenterology .2026;[Epub] CrossRef Current Drug Development Pipeline for MASLD and MASH: Focusing on Cardiovascular Comorbidities Veronika A